SafeBeat develops an AI-powered remote monitoring platform for cardiac care, specializing in atrial fibrillation. Their software integrates with FDA-cleared wearables and mobile phones, enabling clinical teams to remotely monitor patients, analyze ECG data, and manage cardiac medications. The company aims to revolutionize therapeutic management by allowing patients to safely initiate and manage treatment from home.
$135.0K
3
| Customer | Success Story | Source |
|---|---|---|
| UCSF began enrollment for a clinical trial using SafeBeat Rx's AI-based ECG analysis technology for monitoring atrial fibrillation patients. | ||
| Cardiac Therapeutics is powered by Safebeat Rx's ECG software, which is used in a take-home solution combining FDA-cleared wearables with their ECG software to quickly catch heart rhythm changes for decision making. |
Sign up to Ethos to access the full customer list, plus detailed competitor and product analysis.
Sign up to Ethos